A biomarker panel for acute graft-versus-host disease
Sophie Paczesny(MUSC Hollings Cancer Center), James L.M. Ferrara(Tisch Hospital), Joel Whitfield(University of Michigan), Samir Hanash(The University of Texas MD Anderson Cancer Center), Kenneth R. Cooke(Johns Hopkins University), John E. Levine(Icahn School of Medicine at Mount Sinai), Angela C. Weyand(University of Michigan), Sung Won Choi(University of Michigan), Rork Kuick(Center for Non-Communicable Diseases), Carrie L. Kitko(Vanderbilt University Medical Center), Pavan Reddy(Wichita State University), David E. Misek(Center for Non-Communicable Diseases), Thomas Braun(University of Michigan), Dawn Jones(University of Michigan), Daniel Bickley(University of Michigan), Oleg I. Krijanovski, Shawn G. Clouthier(University of Michigan)
Cited by 404
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612